Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Key Takeaways Retatrutide is a new drug emerging as a potential heavyweight contender for post-pregnancy weight loss, acting on three appetite-regulating hormones at once
KFF recently reported that GLP-1 drug discontinuation was more common in those over 65, although this could change if Medicare begins to cover these medications for those without diabetes
27 Similarly, a different group (Morningstar Equities) predicts that GLP-1 prices could begin to fall 10%-15% per year beginning in 2027
But they come with trade-offs in regulatory oversight and quality standardization that you should understand before making a decision
